Author: Moghadasian Mohammed H
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.1, Iss.3, 2002-09, pp. : 269-274
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis
Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. :
Statins: safety and pharmacological interactions
By Di Girolamo Guillermo González Claudio
Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. :
Safety labelling changes for statins
Reactions Weekly, Vol. 1, Iss. 1392, 2012-01 ,pp. :